Stocks

Avalo Therapeutics AVTX

Health care sectorNasdaq

What to see in Avalo Therapeutics now

Is Wall Street adding or cutting?+29

126 13F filers hold it · +29 against the quarter before · shares held +132.4%

Holdings of 06/30
Who bought more than 5%?3.5%

Nantahala Capital Management holds 3.54% · −5.8pp on the report before

Filed 08/14
What comes next?10/15 (Thu)

10/15 estimated earnings

Due 10/15

Company

Exchange
Nasdaq
Industry
Pharmaceutical Preparations
Headquarters
Wayne, Pennsylvania
Fiscal year end
12/31
Next earnings
10/15, estimated
  • 10/15 estimated earningsDue 10/15
Exchange
Nasdaq
Headquarters
Pennsylvania
SIC code
Pharmaceutical Preparations
Fiscal year end
12/31
Next earnings (estimated)
10/15
Last earnings filing
08/06
Korean holdings rank
Outside the top 50

The next earnings day is estimated from the spacing of the last four quarters' 8-K filings.

Korea Securities Depository · released 09/22

Corporate actions

26-week trading